Breaking News Instant updates and real-time market news.

SRTS

Sensus Healthcare

$2.49 /

+0.08 (+3.32%)

16:53
11/05/20
11/05
16:53
11/05/20
16:53

Sensus Healthcare reports Q3 EPS (10c), consensus (13c)

Reports Q3 revenue $1.62M, consensus $2.04M."Our revenues improved sequentially during the third quarter, although our business continues to be significantly impacted by the COVID-19 pandemic," said Joe Sardano, chairman and chief executive officer of Sensus Healthcare. "While our physician customers are focused on rebuilding patient traffic, we have used the past months wisely to lay the foundation for what we believe will be a profitable 2021. We continued to maintain strong customer ties via consistent outreach and sponsorship of helpful Zoom meetings with topics of interest to our customers. We continued to affirm SRT as an attractive alternative to Mohs surgery, as physicians are reluctant to incur the risks of infection and adverse events during this time. Our communications also included the recent American Society of Radiation Oncology's recommendation of SRT as the first-line alternative to surgery when treating patients with non-melanoma skin cancer. In addition, a retrospective study was published in October in the Journal of Clinical and Aesthetic Dermatology showing keloidectomy followed by SRT had an approximate 10% recurrence rate, compared with an expected recurrence rate of more than 80% following surgical excision alone. We believe that SRT will become a standard of care for keloid treatment as awareness grows. "With respect to reimbursement for SRT, we continue to work with the Centers for Medicare & Medicaid Services in order to revalue our main SRT billing code upward by January 2, 2021. While we do expect an increase in reimbursement, we have been actively engaged in providing information to the Relative Value Scale Update Committee. Final reimbursement levels will be determined in December. We believe given the efficacy and patient-friendly attributes of SRT for the treatment of non-melanoma skin cancer, reimbursement levels will be commensurate with the value of the treatment. We are also looking forward to benefitting from our new director Megan Cornish's advice as we work with U.S. government entities.

  • 05

    Nov

  • 17

    Nov

SRTS Sensus Healthcare
$2.49 /

+0.08 (+3.32%)

08/10/20 Alliance Global Partners
Sensus Healthcare upgraded to Buy from Neutral at Alliance Global Partners
06/04/20 Northland
Sensus Healthcare initiated with an Outperform at Northland
05/06/20 Alliance Global Partners
Alliance Global downgrades Sensus to Neutral ahead of results
05/06/20 Alliance Global Partners
Sensus Healthcare downgraded to Neutral from Buy at Alliance Global Partners

TODAY'S FREE FLY STORIES

Recommendations
NIO notes chip shortage remains key production constraint, says Citi » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
NIO

NIO

$33.67 /

-1.195 (-3.43%)

Citi analyst Jeff Chung…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

05/11/21 Wedbush
Tesla April China deliveries see some softness, China tensions key, says Wedbush
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/03/21 Morgan Stanley
NIO on track for Q2 target after April deliveries, says Morgan Stanley
05/03/21 Mizuho
NIO price target raised to $65 from $60 at Mizuho
NIO NIO
$33.67 /

-1.195 (-3.43%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

Earnings
Haemonetics sees FY22 adjusted EPS $2.60-$3.00, consensus $3.48 » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
HAE

Haemonetics

$59.85 /

+0.225 (+0.38%)

Sees FY22 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

04/20/21 Raymond James
CSL's Haemonetics contract end due to Terumo agreement, says Raymond James
04/20/21 Jefferies
Jefferies says 'premature' to permanently exclude CSL as Haemonetics customer
04/20/21 Morgan Stanley
Haemonetics downgraded to Equal Weight from Overweight at Morgan Stanley
04/20/21 Needham
Haemonetics price target lowered to $108 from $158 at Needham
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

Upgrade
Albemarle upgraded to Sector Perform from Underperform at RBC Capital » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
ALB

Albemarle

$154.71 /

-5.575 (-3.48%)

RBC Capital analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

05:29 Today RBC Capital
Albemarle upgraded to Sector Perform from Underperform at RBC Capital
05/12/21 Wells Fargo
Albemarle price target raised to $175 from $162 at Wells Fargo
05/10/21 Citi
Albemarle price target raised to $191 from $174 at Citi
05/07/21
Fly Intel: Top five analyst upgrades
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

  • 04
    Feb
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

Earnings
MultiPlan sees 2021 revenue $1.04B-$1.10B, consensus $1.03B » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
MPLN

MultiPlan

$6.15 /

-0.655 (-9.63%)

Sees 2021 Adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
03/19/21 Barclays
MultiPlan initiated with an Equal Weight at Barclays
03/11/21 Citi
Citi 'scratching our heads' over MultiPlan not issuing 2021 guidance
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

Hot Stocks
Second Sight announces year three NIH funding of Orion study » 06:07
05/13/21
05/13
06:07
05/13/21
06:07
EYES

Second Sight

$6.31 /

+1.35 (+27.22%)

Second Sight announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

Earnings
MultiPlan reports Q1 EPS 7c, consensus 1c » 06:07
05/13/21
05/13
06:07
05/13/21
06:07
MPLN

MultiPlan

$6.15 /

-0.655 (-9.63%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
03/19/21 Barclays
MultiPlan initiated with an Equal Weight at Barclays
03/11/21 Citi
Citi 'scratching our heads' over MultiPlan not issuing 2021 guidance
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

Upgrade
First Hawaiian upgraded to Neutral from Sell at UBS » 06:06
05/13/21
05/13
06:06
05/13/21
06:06
FHB

First Hawaiian

$27.01 /

-1.21 (-4.29%)

UBS analyst Brock…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FHB First Hawaiian
$27.01 /

-1.21 (-4.29%)

FHB First Hawaiian
$27.01 /

-1.21 (-4.29%)

11/19/20 JPMorgan
First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan
07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
FHB First Hawaiian
$27.01 /

-1.21 (-4.29%)

Hot Stocks
Yeti CEO says 'exceptional start to the year' » 06:06
05/13/21
05/13
06:06
05/13/21
06:06
YETI

Yeti

$81.51 /

-6.12 (-6.98%)

Matt Reintjes, President…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

05/12/21 BTIG
Yeti price target raised to $100 from $90 at BTIG
05/11/21 Piper Sandler
Yeti price target raised to $97 from $95 at Piper Sandler
05/10/21 Baird
Yeti price target raised to $100 from $87 at Baird
05/04/21 Jefferies
Yeti price target raised to $115 from $100 at Jefferies
YETI Yeti
$81.51 /

-6.12 (-6.98%)

  • 28
    May
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

Downgrade
Athene Holding downgraded to Neutral from Buy at UBS » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
ATH

Athene Holding

$60.37 /

-2.08 (-3.33%)

UBS downgraded Athene…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

05/10/21 RBC Capital
Athene Holding price target raised to $60 from $55 at RBC Capital
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform at Oppenheimer
04/06/21 RBC Capital
Athene Holding price target raised to $55 from $48 at RBC Capital
04/05/21
Fly Intel: Top five analyst downgrades
ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

Earnings
Haemonetics reports Q4 adjusted EPS 46c, consensus 67c » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
HAE

Haemonetics

$59.85 /

+0.225 (+0.38%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

04/20/21 Raymond James
CSL's Haemonetics contract end due to Terumo agreement, says Raymond James
04/20/21 Jefferies
Jefferies says 'premature' to permanently exclude CSL as Haemonetics customer
04/20/21 Morgan Stanley
Haemonetics downgraded to Equal Weight from Overweight at Morgan Stanley
04/20/21 Needham
Haemonetics price target lowered to $108 from $158 at Needham
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

Periodicals
Tesla Model 3 driver arrested for operating car from back seat, WSJ reports » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
TSLA

Tesla

$590.12 /

-26.78 (-4.34%)

The California Highway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

05/12/21 JPMorgan
JPMorgan says reports on Tesla halting Shanghai expansion are inaccurate
05/11/21 Piper Sandler
Piper says 'hard to draw meaningful conclusions' from 'messy' Tesla China data
05/11/21 Wedbush
Tesla April China deliveries see some softness, China tensions key, says Wedbush
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

Recommendations
Vroom price target lowered to $58 from $60 at Piper Sandler » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
VRM

Vroom

$35.44 /

-1.4 (-3.80%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$35.44 /

-1.4 (-3.80%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.44 /

-1.4 (-3.80%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.44 /

-1.4 (-3.80%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

Upgrade
Funko upgraded to Buy from Neutral at BofA » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
FNKO

Funko

$21.27 /

-2.11 (-9.02%)

BofA analyst Alexander…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FNKO Funko
$21.27 /

-2.11 (-9.02%)

FNKO Funko
$21.27 /

-2.11 (-9.02%)

05/07/21 Truist
Funko price target raised to $25 from $18 at Truist
05/07/21 DA Davidson
Funko upgraded to Buy from Neutral at DA Davidson
05/07/21 DA Davidson
Funko upgraded to Buy from Neutral at DA Davidson
04/19/21 JPMorgan
Funko price target raised to $25 from $20 at JPMorgan
FNKO Funko
$21.27 /

-2.11 (-9.02%)

FNKO Funko
$21.27 /

-2.11 (-9.02%)

FNKO Funko
$21.27 /

-2.11 (-9.02%)

FNKO Funko
$21.27 /

-2.11 (-9.02%)

Recommendations
Chipotle price target raised to $2,100 from $2,000 at Piper Sandler » 06:04
05/13/21
05/13
06:04
05/13/21
06:04
CMG

Chipotle

$1,342.58 /

-50.05 (-3.59%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

05/10/21 Stephens
Chipotle will quickly raise prices to offset wage hike, says Stephens
04/27/21 RBC Capital
Chipotle price target raised to $1,750 from $1,730 at RBC Capital
04/23/21 Deutsche Bank
Chipotle price target raised to $1,495 from $1,462 at Deutsche Bank
04/22/21 Evercore ISI
Chipotle price target raised to $1,725 from $1,650 at Evercore ISI
CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

Earnings
Yeti raises FY21 adjusted EPS view to $2.28-$2.32 from $2.11-$2.14 » 06:02
05/13/21
05/13
06:02
05/13/21
06:02
YETI

Yeti

$81.51 /

-6.12 (-6.98%)

FY21 consensus $2.17.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

05/12/21 BTIG
Yeti price target raised to $100 from $90 at BTIG
05/11/21 Piper Sandler
Yeti price target raised to $97 from $95 at Piper Sandler
05/10/21 Baird
Yeti price target raised to $100 from $87 at Baird
05/04/21 Jefferies
Yeti price target raised to $115 from $100 at Jefferies
YETI Yeti
$81.51 /

-6.12 (-6.98%)

  • 28
    May
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

Initiation
Coinbase initiated with a Neutral at Compass Point » 06:02
05/13/21
05/13
06:02
05/13/21
06:02
COIN

Coinbase

$283.50 /

-19.35 (-6.39%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COIN Coinbase
$283.50 /

-19.35 (-6.39%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

05/10/21 Oppenheimer
Oppenheimer starts Coinbase at Outperform with $434 price target
05/10/21 Oppenheimer
Coinbase initiated with an Outperform at Oppenheimer
05/04/21
Fly Intel: Top five analyst initiations
05/04/21 Mizuho
Coinbase price target raised to $315 from $285 at Mizuho
COIN Coinbase
$283.50 /

-19.35 (-6.39%)

  • 14
    Apr
COIN Coinbase
$283.50 /

-19.35 (-6.39%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

Hot Stocks
Microsoft shutting down Azure Blockchain service on September 10 » 06:00
05/13/21
05/13
06:00
05/13/21
06:00
MSFT

Microsoft

$239.05 /

-7.18 (-2.92%)

, BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

Microsoft is shutting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

BTC Bitcoin
/

+

$BTC Bitcoin
/

+

MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

05/12/21 Rosenblatt
Microsoft initiated with a Buy at Rosenblatt
05/11/21 Morgan Stanley
Morgan Stanley downgrades Nuance, doesn't see Microsoft deal being beat
05/07/21 LightShed Partners
LightShed Partners starts Roblox at Buy with $85 price target
04/28/21 Wedbush
Microsoft price target raised to $310 from $300 at Wedbush
BTC Bitcoin
/

+

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
$BTC Bitcoin
/

+

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

BTC Bitcoin
/

+

$BTC Bitcoin
/

+

MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

BTC Bitcoin
/

+

$BTC Bitcoin
/

+

MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

BTC Bitcoin
/

+

$BTC Bitcoin
/

+

MSFT Microsoft
$239.05 /

-7.18 (-2.92%)

Earnings
Yeti reports Q1 adjusted EPS 38c, consensus 21c » 06:00
05/13/21
05/13
06:00
05/13/21
06:00
YETI

Yeti

$81.51 /

-6.12 (-6.98%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

05/12/21 BTIG
Yeti price target raised to $100 from $90 at BTIG
05/11/21 Piper Sandler
Yeti price target raised to $97 from $95 at Piper Sandler
05/10/21 Baird
Yeti price target raised to $100 from $87 at Baird
05/04/21 Jefferies
Yeti price target raised to $115 from $100 at Jefferies
YETI Yeti
$81.51 /

-6.12 (-6.98%)

  • 28
    May
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

Upgrade
Evercore upgrades Pure Storage on 'unique and transient opportunity' » 06:00
05/13/21
05/13
06:00
05/13/21
06:00
PSTG

Pure Storage

$17.02 /

-0.84 (-4.70%)

Evercore ISI analyst Amit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSTG Pure Storage
$17.02 /

-0.84 (-4.70%)

PSTG Pure Storage
$17.02 /

-0.84 (-4.70%)

05:20 Today Evercore ISI
Pure Storage upgraded to Outperform from In Line at Evercore ISI
04/23/21 KeyBanc
Pure Storage resumed with an Overweight at KeyBanc
04/05/21 JPMorgan
JPMorgan sees Pure Storage as reopening trade after customer survey
03/15/21 Raymond James
Pure Storage upgraded to Strong Buy from Outperform at Raymond James
PSTG Pure Storage
$17.02 /

-0.84 (-4.70%)

PSTG Pure Storage
$17.02 /

-0.84 (-4.70%)

PSTG Pure Storage
$17.02 /

-0.84 (-4.70%)

Upgrade
Chatham Lodging upgraded to Buy on share pullback at Stifel » 05:57
05/13/21
05/13
05:57
05/13/21
05:57
CLDT

Chatham Lodging

$12.10 /

-0.47 (-3.74%)

Stifel analyst Simon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLDT Chatham Lodging
$12.10 /

-0.47 (-3.74%)

CLDT Chatham Lodging
$12.10 /

-0.47 (-3.74%)

05/12/21 Stifel
Chatham Lodging upgraded to Buy from Hold at Stifel
03/01/21 B. Riley Securities
Chatham Lodging price target raised to $14 from $12 at B. Riley Securities
01/05/21 Janney Montgomery Scott
Chatham Lodging upgraded to Buy from Neutral at Janney Montgomery Scott
01/05/21 Janney Montgomery Scott
Chatham Lodging upgraded to Buy from Neutral at Janney Montgomery Scott
Upgrade
KeyBanc upgrades Pioneer Natural on potential guidance upside » 05:55
05/13/21
05/13
05:55
05/13/21
05:55
PXD

Pioneer Natural

$156.08 /

-1.79 (-1.13%)

KeyBanc analyst Leo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PXD Pioneer Natural
$156.08 /

-1.79 (-1.13%)

PXD Pioneer Natural
$156.08 /

-1.79 (-1.13%)

05/12/21 KeyBanc
Pioneer Natural upgraded to Overweight from Sector Weight at KeyBanc
05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Truist
Pioneer Natural downgraded to Hold from Buy at Truist
05/06/21 Truist
Pioneer Natural downgraded to Hold from Buy at Truist
PXD Pioneer Natural
$156.08 /

-1.79 (-1.13%)

  • 11
    May
PXD Pioneer Natural
$156.08 /

-1.79 (-1.13%)

PXD Pioneer Natural
$156.08 /

-1.79 (-1.13%)

PXD Pioneer Natural
$156.08 /

-1.79 (-1.13%)

Conference/Events
Cree participates in a conference call with Benchmark » 05:55
05/13/21
05/13
05:55
05/13/21
05:55
CREE

Cree

$88.50 /

-4.84 (-5.19%)

Hardware Analyst Miller…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CREE Cree
$88.50 /

-4.84 (-5.19%)

CREE Cree
$88.50 /

-4.84 (-5.19%)

05/10/21 JPMorgan
Cree upgraded to Neutral on valuation at JPMorgan
05/10/21 JPMorgan
Cree upgraded to Neutral from Underweight at JPMorgan
04/29/21
Fly Intel: Top five analyst downgrades
04/29/21 Canaccord
Cree price target raised to $126 from $120 at Canaccord
CREE Cree
$88.50 /

-4.84 (-5.19%)

CREE Cree
$88.50 /

-4.84 (-5.19%)

CREE Cree
$88.50 /

-4.84 (-5.19%)

Conference/Events
Ares Commercial management to meet virtually with JMP Securities » 05:55
05/13/21
05/13
05:55
05/13/21
05:55
ACRE

Ares Commercial

$14.09 /

-0.66 (-4.47%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACRE Ares Commercial
$14.09 /

-0.66 (-4.47%)

ACRE Ares Commercial
$14.09 /

-0.66 (-4.47%)

04/26/21 JPMorgan
Ares Commercial price target raised to $13.50 from $12.50 at JPMorgan
02/02/21 BTIG
Ares Commercial initiated with a Buy at BTIG
11/20/20 Raymond James
Ares Commercial downgraded to Outperform from Strong Buy at Raymond James
11/20/20 Raymond James
Ares Commercial downgraded to Outperform from Strong Buy at Raymond James
ACRE Ares Commercial
$14.09 /

-0.66 (-4.47%)

  • 16
    Mar
Upgrade
BJ's Wholesale upgraded on potential Q1 upside at JPMorgan » 05:53
05/13/21
05/13
05:53
05/13/21
05:53
BJ

BJ's Wholesale

$43.47 /

-3.06 (-6.58%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BJ BJ's Wholesale
$43.47 /

-3.06 (-6.58%)

BJ BJ's Wholesale
$43.47 /

-3.06 (-6.58%)

05:30 Today JPMorgan
BJ's Wholesale upgraded to Overweight from Neutral at JPMorgan
03/16/21 MKM Partners
BJ's Wholesale price target lowered to $39 from $41 at MKM Partners
03/05/21 DA Davidson
BJ's Wholesale price target lowered to $50 from $55 at DA Davidson
03/05/21 Deutsche Bank
BJ's Wholesale price target lowered to $43 from $47 at Deutsche Bank
BJ BJ's Wholesale
$43.47 /

-3.06 (-6.58%)

BJ BJ's Wholesale
$43.47 /

-3.06 (-6.58%)

Upgrade
Opco upgrades Lowe's on 'historically discounted valuation' to Home Depot » 05:50
05/13/21
05/13
05:50
05/13/21
05:50
LOW

Lowe's

$195.57 /

-9.77 (-4.76%)

, HD

Home Depot

$317.00 /

-13.38 (-4.05%)

Oppenheimer analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOW Lowe's
$195.57 /

-9.77 (-4.76%)

HD Home Depot
$317.00 /

-13.38 (-4.05%)

LOW Lowe's
$195.57 /

-9.77 (-4.76%)

05:22 Today Oppenheimer
Lowe's upgraded to Outperform from Perform at Oppenheimer
05/05/21 Wells Fargo
Lowe's price target raised to $225 from $210 at Wells Fargo
05/04/21 Citi
Lowe's price target raised to $239 from $195 at Citi
04/19/21 JPMorgan
Lowe's price target raised to $204 from $177 at JPMorgan
HD Home Depot
$317.00 /

-13.38 (-4.05%)

05/05/21 Wells Fargo
Home Depot price target raised to $360 from $330 at Wells Fargo
05/04/21 Citi
Home Depot price target raised to $375 from $288 at Citi
04/28/21 Argus
UPS price target raised to $220 from $185 at Argus
04/19/21 JPMorgan
Home Depot price target raised to $330 from $285 at JPMorgan
LOW Lowe's
$195.57 /

-9.77 (-4.76%)

HD Home Depot
$317.00 /

-13.38 (-4.05%)

LOW Lowe's
$195.57 /

-9.77 (-4.76%)

HD Home Depot
$317.00 /

-13.38 (-4.05%)

LOW Lowe's
$195.57 /

-9.77 (-4.76%)

HD Home Depot
$317.00 /

-13.38 (-4.05%)

LOW Lowe's
$195.57 /

-9.77 (-4.76%)

HD Home Depot
$317.00 /

-13.38 (-4.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.